Details of the Drug

General Information of Drug (ID: DMFGADW)

Drug Name
CTX-1301
Indication
Disease Entry ICD 11 Status REF
Attention deficit hyperactivity disorder 6A05.Z Phase 1 [1]
Cross-matching ID
TTD ID
D0Z9QX

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)